A Fundação Champalimaud procura um(a) Técnico(a) Superior de Medicina Nuclear para prestar serviço a tempo inteiro e em exclusividade no Serviço de Medicina Nuclear-Radiofarmacologia.

TIL for the treatment of patients with solid cancer: an interactive workshop

Personalised T-cell therapy has now reached the solid tumour therapy field as a first of-its-kind immunotherapy for patients with melanoma with an approval granted by the FDA on February 17th  2024.

Cancers become resistant to chemotherapy in two major ways. They either have preexisting resistance to a type of drug or they can develop resistance through mutations.

Here are some of the main reasons for cancer drug resistance to arise. 

The Champalimaud Foundation is looking for Anatomical Pathology Technicians to be part of the Pathology Department team.

Duration

The position has an initial duration of 12 months.

Position

The selected candidates will be part of the technical team of the Anatomic Pathology Service and will work in gross examination, histology, cytology, ancillary techniques, and other laboratory tasks.